Nkarta, Inc. (NKTX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $184 million, Nkarta, Inc. is a micro-cap company. The stock currently trades at $2.63, down 2.59% today, with a 52-week range of $1.31–$2.74.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.60 | $-1.60 | +33.3% | |
| 2023 | $-2.40 | $-2.40 | +8.0% | |
| 2022 | $-2.61 | $-2.61 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — |